DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 1ABC HOLDING
03 7Actavis Inc
04 1Aurobindo Pharma Limited
05 2Aurolife Pharma LLC
06 1Avanthi Pharma
07 3Barr Laboratories
08 2Camall
09 14Chartwell Pharmaceuticals llc
10 3Citius Pharmaceuticals
11 2Crux Pharmaceuticals (Pty) Ltd
12 1DURAMED PHARMS BARR
13 8Elite Laboratories
14 1Ferndale Laboratories, Inc.
15 1GSK
16 1Hanlim Pharmaceuticals Inc
17 2IVAX Pharmaceuticals Inc
18 5InvaGen Pharmaceuticals Inc
19 6KVK.Tech
20 5Lannett Company, Inc.
21 3MAST MM
22 1Myungmoon Pharm. Co., LTD.
23 1Novast Laboratories
24 4Nuvo Pharmaceuticals
25 1PURACAP LABS BLU
26 2Pharma Dynamics
27 1Prinston
28 1SHIRE PLC
29 11Sandoz B2B
30 1Solvay Chemicals International S.A
31 8Sun Pharmaceutical Industries Limited
32 1TG United
33 8Teva Pharmaceutical Industries
34 4USL PHARMA
35 2Upsher-Smith Laboratories
36 4VITARINE
37 8Vivus
38 3Zydus Pharmaceuticals
01 2CAP
02 12CAPSULE, EXTENDED RELEASE;ORAL
03 1CAPSULE; ORAL
04 70CAPSULE;ORAL
05 2CAS
06 4Capsule For Inhalation
07 2TABLET
08 6TABLET, ORALLY DISINTEGRATING;ORAL
09 35TABLET;ORAL
01 4Approved
02 83DISCN
03 6Generic
04 40RX
05 1Blank
01 2ADIPEX-P
02 1FASTIN
03 1LOMAIRA
04 1Lediphen
05 1Minex 15 mg
06 1Minex 30 mg
07 1OBESTIN-30
08 1OBY-TRIM
09 3ONA-MAST
10 1PENTAGEN
11 98PHENTERMINE HYDROCHLORIDE
12 8PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
13 1PHENTOLENE 15 mg
14 1PHENTOLENE 30 mg
15 4QSYMIA
16 4Qsiva
17 3SUPRENZA
18 1TORA
19 1WILPO
01 4South Africa
02 2South Korea
03 4Sweden
04 124USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
Brand Name : PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 3.75MG BASE;23MG
Packaging :
Approval Date : 2025-06-12
Application Number : 208175
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
Brand Name : PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 7.5MG BASE;46MG
Packaging :
Approval Date : 2025-06-12
Application Number : 208175
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
Brand Name : PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 11.25MG BASE;69MG
Packaging :
Approval Date : 2025-06-12
Application Number : 208175
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
Brand Name : PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 15MG BASE;92MG
Packaging :
Approval Date : 2025-06-12
Application Number : 208175
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PHENTERMINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 37.5MG
Packaging :
Approval Date : 1998-11-25
Application Number : 40276
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PHENTERMINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 37.5MG
Packaging :
Approval Date : 1997-05-30
Application Number : 40190
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PHENTERMINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 1997-06-18
Application Number : 40227
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PHENTERMINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 37.5MG
Packaging :
Approval Date : 1997-06-19
Application Number : 40228
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PHENTERMINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2003-01-22
Application Number : 40448
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FASTIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 17352
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PHENTERMINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 37.5MG
Packaging :
Approval Date : 2002-01-04
Application Number : 40377
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : WILPO
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 12737
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PHENTERMINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 37.5MG
Packaging :
Approval Date : 2001-08-30
Application Number : 40402
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PHENTERMINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2001-08-30
Application Number : 40403
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PHENTERMINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2001-08-30
Application Number : 40427
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PHENTERMINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 1997-03-07
Application Number : 40083
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
Brand Name : QSYMIA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 3.75MG BASE;23MG
Packaging :
Approval Date : 2012-07-17
Application Number : 22580
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
Brand Name : QSYMIA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 7.5MG BASE;46MG
Packaging :
Approval Date : 2012-07-17
Application Number : 22580
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
Brand Name : QSYMIA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 11.25MG BASE;69MG
Packaging :
Approval Date : 2012-07-17
Application Number : 22580
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
Brand Name : QSYMIA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 15MG BASE;92MG
Packaging :
Approval Date : 2012-07-17
Application Number : 22580
Regulatory Info : RX
Registration Country : USA
